header logo image


Page 417«..1020..416417418419..430440..»

LIve Life Fully: Keys to happiness and longevity – Charleston Gazette-Mail

August 19th, 2020 2:53 pm

You can have more purpose and greater happiness in the second half of your life.

Thats certainly reassuring, especially if youve spent the first part of your life getting through school, getting a job, possibly getting married, starting a family and, generally, living on autopilot.

This quote comes from author Dan Buettner, author of The Blue Zones of Happiness and The Blue Zones: Nine Lessons for Living Longer. Buettner is a National Geographic fellow who has produced an Emmy-winning documentary and holds three world records for endurance cycling.

Working with the National Geographic, Buettner has studied regions of the world in which people live longer and are happier. He refers to these as blue zones.

If happiness were a cake recipe, Buettner says, the ingredients would include: food, shelter, health care, education, mobility/movement, having a partner in life, sleep, faith, a pet, a positive attitude and a sense of purpose.

Research also shows four common characteristics of those who live long, healthy lives:

n Something to look forward to

And the No. 1 factor of the happiest and healthiest populations might surprise you: deep friendships.

Friendships and loneliness

How you curate your immediate social network is probably the biggest lasting thing you can do to improve your life, Buettner explains. You need three to five good friends, he says. People with whom you can have a meaningful conversation not just about current events or sports. Its safe to be vulnerable with them and cry on their shoulders. They listen without judgment.

This dovetails with the work of hospice nurse Bronnie Ware, who chronicled insights from those on their death beds in her book The Top Five Regrets of the Dying. One of the regrets mentioned most often: I wish Id stayed in closer touch with friends.

Loneliness is a huge factor in both unhappiness and longevity.

Its as dangerous as a smoking habit, Buettner says, shaving six to eight years off your life expectancy age.

Lonely people are more susceptible to stress, depression and dementia. And theyre more likely to commit suicide.

Social media can fill this void to some extent. However, theres a big caution flag. Its healthy to engage for about a half-hour to an hour a day, to stay in touch and learn a few things. After 1 hours of social media exposure, though, things start to go downhill dramatically. And those who spend eight hours a day are the least happy. So, you may want to do the math on your usage.

The blue zones of longevity

The following areas have been identified as having the greatest number of people who lead long, healthy lives, well into their 90s and 100s:

1. Loma Linda, California

2. Nicoya Peninsula, Costa Rica

The United States ranks No. 19 on the longevity scale with a grade of B. The average American loses about 12 years of life due to a toxic food environment, inadequate social relationships and a lack of physical activity.

So, what is it about blue zones that produces happier people who live longer? They dont have greater discipline, Buettner says.

Theyre just in environments where the healthiest choice is either the easiest choice or the unavoidable one, he explains.

Simple foods are plentiful around them nuts, beans and greens. And the option of loneliness doesnt exist. If theyre not showing up for church or the village festival, someone is knocking on their door and getting them out. The option of being sedentary is not there, either. Theyre being nudged moving more, eating less and eating more plant-based foods.

They also have purpose. They dont wake up every day asking, What should I be doing today? Whats my life meaning? Theres no existential stress because their lives revolve around family, faith and community.

Its all about connection.

Happiness factors

One of the biggest barriers to longevity is unhappiness. This condition could take eight years off ones life expectancy.

National Geographic and Buettner conducted a survey of 150,000 people, entitled the True Happiness Test.

According to Buettner, 40% of what makes us happy is genetic. Fifteen percent is chance. However, that leaves nearly half the equation up to the individual. Following are some research results on common health practices.

n Vitamins: Interestingly, Buettner says their studies found that taking vitamins doesnt make much of an impact on greater longevity. He notes there are situational cases where this might make a difference. Overall, though, he says were too prone to calling an 800 number to get the latest and greatest supplement. Theres no silver bullet.

n Sleep: Forgoing sleep in pursuit of goals is harmful. Sleep is when our bodies do cellular repair.

If youre only sleeping six hours a day, youre going to be about 30% less happy, says Buettner. Tired feelings make you feel crappy. Youre also less proficient at work and more likely to be obese. Buettner says we need eight to nine-and-a-half hours of sleep a night.

n Movement and exercise: Forty-five minutes of daily exercise is recommended. This can be broken up into segments.

n Pets: Bonding with a pet has been shown to raise levels of oxytocin, one of the happy hormones. And going for walks also could release endorphins, more feel good brain chemicals.

Daily rituals to reduce stressMeditation and prayer time, taking naps and engaging in a happy hour have all been shown to be effective at reducing stress. Again, the best medicine for unhappiness is a social network. Volunteer. Find a spiritual community, a group of walkers or a bridge group. Admittedly, this is more challenging during our pandemic period.

Set up things up in your environment so you dont have to think about them. Keep the fruit bowl full so you wont be as tempted to go to the junk food drawer.

The true happiness test

You can take the True Happiness Test by doing an online search of true happiness test. Its a free five-minute survey.

Its never too late to start snatching back some good years, says John Day, co-author of The Longevity Plan. The best time is to start from childhood. The second best time is today.

2020 Linda Arnold Live Life Fully, all rights reserved. Linda Arnold, M.A., M.B.A., is a syndicated columnist, psychological counselor and founder of a multistate marketing company. Reader comments are welcome at linda@lindaarnold.org For information on her books, go to http://www.lindaarnold.org or Amazon.com.

See the article here:
LIve Life Fully: Keys to happiness and longevity - Charleston Gazette-Mail

Read More...

A Healthy Improvement on GDP by Andrew Scott – Project Syndicate

August 19th, 2020 2:53 pm

Many of the failures of GDP as a measure of economic performance are well known. Policymakers in search of an alternative should recognize the far-reaching power of healthy life expectancy as a measure not only of individual wellbeing, but of broader macroeconomic conditions as well.

LONDON Dissatisfaction about GDP is growing. Many economists, policymakers, and other critics question the ability of this central measure of government and social success to recognize the welfare gains from technology, account for environmental degradation, or capture rising inequality. With developments in artificial intelligence and robotics poised to produce considerable labor-market churn while also boosting GDP a process likely to be accelerated by the ongoing pandemic these complaints will soon grow louder.

Numerous alternative indicators have long been on offer, but one especially promising option is healthy life expectancy (HLE), a metric that is easily understood and that has obvious importance to each of us individually. Moreover, HLE is already being measured, and happens to address many of the factors that GDP might omit.

Poor environmental conditions, for example, are not conducive to long, healthy lives. And there is plenty of evidence to suggest that individuals who are happy and fulfilled also tend to live longer and remain healthy for longer. Even more to the point, longer healthier lives connect back to GDP itself. Just as rising GDP helps to provide the resources needed to support health, healthy populations support stronger GDP.

Moreover, by targeting HLE specifically, governments could shine a brighter light on the issue of economic inequality. Because the incomes of the very richest households may be several thousand times greater than those of the poorest households, average GDP is invariably larger than typical (median) income. But when it comes to life expectancy in the richest countries, the opposite is true. The outliers tend to be those who die young, so that typical (median) life expectancy is higher than average life expectancy.

This means that raising the average HLE can be achieved by raising the HLE of those at the bottom of the health distribution to that of the typical (median) person. This not only makes targeting inequality more attractive, but does not require path-breaking medical innovations to achieve longer lifespans just the achievement of typical outcomes for more people. With this in mind, it is urgent to close the sizeable rich-poor life-expectancy gap around 15 years in the United States.

As a metric for economic and social progress, targeting HLE implicitly acknowledges that aging is malleable (if it wasnt, it wouldnt be a viable target). It turns out that a range of behaviors and policies, as well as the environment we inhabit, influence how we age and how long we live. It is estimated that our genetics account for only one-quarter of the factors contributing to how we age. Given this malleability, it is crucial that governments focus on HLE for the maximum number of people.

Enjoy unlimited access to the ideas and opinions of the world's leading thinkers, including weekly long reads, book reviews, and interviews; The Year Ahead annual print magazine; the complete PS archive; and more all for less than $2 a week.

Subscribe Now

Such a focus would also help governments confront one of the biggest challenges of the future: societal aging. Given that every country in the world is expected to experience societal aging, focusing on how well we age becomes paramount. This age malleability requires drawing a distinction between chronological and biological measures of age and focusing on the latter.

Yet, because so much government policy currently focuses on the non-malleable chronological metric, too many governments are unprepared for future demographic challenges such as overburdened health and pension systems. Rather than exploring ways to influence how we age, policymakers are focused almost entirely on the number of old people. But by targeting healthy longevity, they could help more people lead longer, more productive lives, thereby minimizing the economic costs of societal aging.

After the 2008 financial crisis, policymakers committed to doing whatever it takes to stabilize the financial system and restore GDP growth. A subsequent slowdown in trend productivity growth and the devastating global economic fallout from the current pandemic have produced numerous policy suggestions and unprecedented spending aimed at reversing trend slowdowns in GDP growth.

By contrast, news of declining life expectancy in many OECD countries has not produced a similar outpouring of proposed solutions. How can we commit trillions of dollars to ensure that GDP is supported while doing so little to avoid declining life expectancy? Certainly, the response to COVID-19, where GDP has plummeted as a result of life-saving measures, suggests that substantial policy measures to boost HLE are worthwhile.

To operationalize HLE targeting, governments should follow Japan in establishing longevity councils. Once policymakers start focusing on the issue, they will realize three things. First, preventive health care is key. Around the world, health systems tend to be geared primarily toward medical intervention and disease response, rather than toward general health promotion. Second, and relatedly, many of the determinants of long, healthy lives fall outside the health system, and are connected to work, education, and community, as economists Anne Case and Angus Deaton have shown in their work documenting deaths of despair. A policy focus on HLE therefore requires a cross-departmental government approach.

The fact that todays deaths of despair disproportionately affect middle-aged individuals points to the third realization: longevity is about all-of-life and not just end-of-life outcomes. With the British government estimating that a newborn girl now has a one-in-five chance of living to 100, it is critical that we expand our view of longevity to the entire life course. Measures targeting HLE must be inclusive across all age cohorts and focus on longevity, not just on the old. After all, todays young people are tomorrows elderly, and all of ones time on this planet matters.

There are many metrics that governments could use to judge the success of their policies and the health of society. But whatever other measures they use, HLE deserves a central position in the policy mix. Few other variables are both as important for us individually and as effective in capturing broader macroeconomic benefits.

Visit link:
A Healthy Improvement on GDP by Andrew Scott - Project Syndicate

Read More...

Lapetus Solutions: The Face Of InsurTech by Diane Durance | Sponsored Insights – Greater Wilmington Business Journal

August 19th, 2020 2:53 pm

Instead of tea leaves or Tarot Cards, Lapetus Solutions uses proprietary algorithms and AI to predict your future by reading your face.

Has Covid-19 impacted Lapetus? Karl Ricanek, Jr., PhD, co-founder and chief AI scientist, says its an interesting time for the company. Applications for life settlements and life insurance have slowed with consumers resisting the in-person contact required for medical exams. Individuals are reluctant to sell life insurance policies with the uncertain trajectory of the pandemic. Still, the need for data to support decisions on these policies continues to grow; Lapetus had one life estimate client 18 months ago and has a dozen today.

Increasingly, insurance carriers want to expedite health assessments for rapid underwriting. With the Lapetus medical selfie and answers to a set of questions, new policies can be underwritten in minutes instead of weeks. Historically, blood and urine samples were collected during an in-person paramed exam. The pandemic has made scheduling these difficult. In South Africa, for instance, paramed exams were prohibited this spring, leading a carrier there to turn to Lapetus for a better solution.

The need for longevity data for large-scale annuity programs is ramping up. Lapetus recently inked a deal to provide individual longevity estimates for an Asian country to determine risk profiles for new Social Security-like government-backed annuities for its citizens. Accurate data will assure the program is adequately funded.

How about a personal assessment? Lapetus offers a genetic test developed by their scientists to determine whether you have the genes for exceptional longevity. Start with a 23 and Me report on your ancestry, then share the data with Lapetus to gain additional health information, including your potential for early onset Alzheimers and other chronic diseases.

Lapetus got its start with a phone call seven years ago when cofounder, S. Jay Olshansky, PhD, chief science officer, said Hey, I have this crazy idea and youre the only person that can build this technology. At the time, Ricanek was working on a U.S. Government sponsored project and questioning why chronological age algorithm accurately predicted age using facial analytics for 80% of test subjects, but not the other 20%. It turns out he was accurately measuring something else biological age. Senescencing is the rate at which subjects biologically age. Some people senescence faster due to genetic contributors and extrinsic factors (including alcohol use, depression, and smoking) and die sooner.

Whats the future of Lapetus? Building out the platform, taking the company public, and exiting? Or setting up a life insurance company for certain products? Growing to be the next largest insurance company in the U.S.? There are multiple paths to a $1B valuation over the next two years.

Fortunately, as Lapetus faces new opportunities, Ricanek continues with research and promoting innovation at UNCW and the CIE. The face of InsurTech in Wilmington is here to stay.

Diane Durance, MPA, is director of UNC Wilmington's Center for Innovation and Entrepreneurship (CIE). The CIE is a resource for the start-up and early-stage business community to help diversify the local economy with innovative solutions. For more information, visit http://www.uncw.edu/cie

Link:
Lapetus Solutions: The Face Of InsurTech by Diane Durance | Sponsored Insights - Greater Wilmington Business Journal

Read More...

Thousands pack water park in Wuhan, China, the once-epicenter of the coronavirus pandemic | TheHill – The Hill

August 19th, 2020 2:53 pm

New images show thousands of people crammed shoulder to shoulder at a massive pool party over the weekend in Wuhan, China, where the coronavirus is thought to have first emerged late last year.

Large crowds packed the Wuhan Playa Maya Water Park for an electronic music festival on Saturday, according to the Agence France-Presse (AFP).

America is changing FASTER THAN EVER. Add Changing America to yourFacebookandTwitterfeeds to stay engaged on the latest news and smartest insights.

Partygoers can be seen standing and swimming in close quarters to one another without the usual mask and social distancing measures meant to curb the spread of the coronavirus as they watched the performance.

The images stand in stark contrast to the strict lockdown that was once imposed on the central Hubei province city in January when the coronavirus outbreak first began spiraling out of control, which locked down Wuhans 11 million residents.

All public transport was suspended and movement outside homes was restricted. The lockdown was lifted in April, around the time the virus began tearing through western Europe and the U.S.

There have been no new domestically transmitted cases officially reported in Hubei province, where Wuhan is the capital, since May according to AFP. More than 68,000 cases have been confirmed in Hubei province with more than 4,500 deaths.

But some have cast doubt on the actual number of coronavirus cases and deaths in China due to the authoritarian nature of the country. China has tallied more than 84,000 cases with a total of 4,634 deaths.

Continue reading here:
Thousands pack water park in Wuhan, China, the once-epicenter of the coronavirus pandemic | TheHill - The Hill

Read More...

In Missouri River, sturgeon dont look their age – University of Georgia

August 19th, 2020 2:53 pm

A new study reveals the secrets of these prehistoric fishand how they adjust to changing conditions

In the lower Missouri River, a fish with prehistoric ties has learned to live hardand, too often, die young.

Now, a new study by a University of Georgia professor details the ways pallid sturgeon have adapted to less-than-ideal conditions. Fish that live where their habitat has substantially changed have responded by growing faster and reaching sexual maturity at an earlier age, resulting in a shortened lifespan.

Though perhaps not ideal, this typically long-lived fish has found a way to persist while facing extinction due to widespread changes in its river system.

The findings are a first for this type of species and the paper, published this month in the journal Scientific Reports, offers vital insight into an endangered species. It details the fishs plasticity, or the ability to adjustrather than genetically adaptto large-scale changes in the environment.

A pallid sturgeon in the wild. (Submitted photo)

While genetic adaptations take place over generations as a result of natural selection, plasticity represents small shifts in a species life history without a genetic adaptation. The amount of plasticity, or variation, is often difficult to determine and is unknown for many organismsespecially long-lived ones such as sturgeon.

For a traditionally long-lived species, this plasticity hasnt been documented before, said Marty Hamel, an assistant professor of fisheries and ecology at the UGA Warnell School of Forestry and Natural Resources. He observed these changes in a portion of the Missouri River that has changed dramatically over the years; now it looks completely different from its historic conditions. So, those environmental influences, they have an impact on age and growth characteristics where they ultimately impact life-history traits like longevity and age and size at sexual maturation.

For example, Hamels research found that adult sturgeon in the lower portion of the river are much smaller in size. This translates to fewer eggs per femalein the order of 15,000 per fish compared with about 121,000 upstream. Because their harsh living conditions require additional energy just to survive, any surplus energy goes toward reproductive activities instead of fish growth, Hamel said.

He also determined that while sturgeon in the upper Missouri could live to be 100 years old, sturgeon in the lower Missouri would live less than half as long, averaging about 39 years. But to do this, Hamel had to mark another first for pallid sturgeon: A way to find their age.

I got all this mark-recapture information and when I came to UGA (in 2019), I started working that up to try and get a formula to estimate the age of these fish, because we had no clue, he said. Mark-recapture refers to a method where an animal is noted over time in different places on the landscape. Theyre an endangered species, so having that age information is really important for understanding the population. Age data are fundamental for many of the metrics we observelike growth and mortality ratesand having that information allows researchers to model or forecast how the species might respond to conservation measures such as habitat improvement projects or restocking strategies.

He added that while there has been a lot of research done on pallid sturgeon in the last decade, there remained this knowledge gap in understanding the complete life history of the fish. Thats something I was interested in, and I found a way to figure it out.

For about 20 years, fish hatcheries have been capturing wild pallid sturgeon, spawning them in captivity and releasing their offspring back into the river. Each fish that is released has a unique PIT tagthe same kind of microchip used to identify household pets if they are lostand when they are caught by researchers later in life, the tags can be scanned to learn how much the fish grew and how far they have traveled from where they were released.

Marty Hamel examining cross sections of fish ear bones. (Submitted photo)

Using this information, Hamel was able to apply known ages of hatchery-raised fish and determine a formula that could be used to estimate age for wild fish. Determining age can be problematic for sturgeonthe age of most fish can be found by examining a cross-section of a pectoral fin or a fishs ear bone. But the reliability of these structures in most sturgeon is poor owing to their slow growth as adults and their environment. So, while they have the potential to live for decades, their age and longevity have largely remained a mystery.

Hamel now plans to build on these analyses by incorporating additional genetic tools and applying this information to sturgeon in the Southeast. Of the nine species found in North America, five can be found in or adjacent to GeorgiaAtlantic, shortnose, Gulf, lake and Alabama sturgeon. Hamel, who has been studying sturgeon for more than a decade, is now pursuing projects that involve all of these fish.

Its all very relatableunderstanding the age structure and longevity of these imperiled sturgeons is vital for management and recovery, he said. For example, up the Northeast coast, Atlantic sturgeon are much larger than those that occupy the coastal rivers of Georgia. If smaller size equates to decreased longevity, these fish will have a reduced number of lifetime reproductive events. That type of information would be really beneficial to aid in recovery efforts.

See the article here:
In Missouri River, sturgeon dont look their age - University of Georgia

Read More...

Just how to live much longer: The foods shown to avoid heart disease and increase longevity – Entertainment Overdose

August 19th, 2020 2:53 pm

Although it is obvious tht food is vitl to onesn>survivl, mny people re unwren>how single compounds found in foods could impct disesen>nd mortlity.n>Leding helth experts nd reserchers recommend diet which is rich in polyphenols to help boost longevity nd reducen>then>risk of diseses.n>n>

In study published in Alph Glileo, diet high in polyphenols nd its ssocition with longevity ws investigted.

The study noted: It is the first time tht scientific study ssocites high polyphenols intke with 30 percent reduction in mortlity in older dults.n>n>

The reserch, published onJournl of Nutrition, is the first to evlute the totl dietry polyphenol intke by using nutritionl biomrker nd not only food frequency questionnire.n>n>

Reserchers found tht people who took in 650 mg per dy experienced 30 percent lower mortlity rte thn those who took in less thn 500 mg per dy.n>n>n>

n>

DONT MISS

Iron deficiency symptoms: The sign in your hair that could mean youre lacking iron[EXCLUSIVE]

Hair loss treatment: Using this oil could unclog hair follicles and increase hair growth[INSIGHT]

Pancreatic cancer symptoms: Having this colour pee could be a sign of the deadly disease[TIPS]

n>

Professor Cristin Andr&ecute;s Lcuev, hed of the Biomrkers nd Nutritionl ∓ Food Metbolomics Reserch Group of the UB nd coordintor of the study sid: The development nd use of nutritionl biomrkers enbles to mke more precise nd, prticulrly, more objective estimtion of intke s it is not only bsed on prticipnts memory when nswering questionnire.n>n>

Nutritionl biomrkers tke into ccount biovilbility nd individul differences.n>n>

This methodology mkes more relible nd ccurte evlution of the ssocition between food intke nd mortlity or disese risk.n>n>

Polyphenolsorpolyphenolrich diets provide significntprotection ginstthe development nd progression of mny chronic pthologicl conditions including cncer, dibetes, crdio-vsculr problems nd ging.n>n>

Polyphenol foods re known to help boost longevity nd fruits with high levels of polyphenols include blck chokeberries, blck elderberries, strwberries, red rspberries, blueberries, plums, ndn>blckcurrnts.n>n>

Coco powder, drk chocolte, coffee, te, nd flxseed re lso high in polyphenols.n>n>

When it comes to herbs nd sesonings withn>highn>levels of polyphenols, the Europen Journl of Clinicl Nutrition recommends cloves, dried peppermint, nd str nise.n>n>

The rest is here:
Just how to live much longer: The foods shown to avoid heart disease and increase longevity - Entertainment Overdose

Read More...

Stocks rally on new U.S. highs, dollar at two-year low – Reuters

August 19th, 2020 2:53 pm

NEW YORK (Reuters) - Global equities rose on Tuesday as strong corporate results and accelerating U.S. homebuilding lifted the S&P 500 past highs set before the coronavirus crushed world economies, in a stimulus-fueled rally that has also pushed the dollar to two-year lows.

FILE PHOTO: The Wall Street sign is pictured at the New York Stock exchange (NYSE) in the Manhattan borough of New York City, New York, U.S., March 9, 2020. REUTERS/Carlo Allegri/File Photo

Both the S&P 500 and Nasdaq Composite set records soon after the opening bell following strong sales growth as reported by major U.S. retailers including Walmart, Kohls and Home Depot.

The benchmark S&P 500 index topped an all-time peak reached in February just before the onset of COVID-19. The tech-heavy Nasdaq hit a record high for the second consecutive day in a session where declining stocks outnumbered rising shares.

(Graphic: S&P 500's bull-to-bear, bear-to-bull journey in 6 months here)

Its a reflection that the pandemic has limited longevity and the economic downtown will also have limited longevity, said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York, who acknowledged many investors are skeptical about a rally that confirms a bull market.

We feel in about a year or so most of the population will be immunized with a vaccine and the economy will begin to return to accelerated growth, Ghriskey said.

Historically low interest rates and very accommodative monetary and fiscal policy in the United States and abroad have aided the rally, said William Northey, senior investment director at U.S. Bank Wealth Management in Helena, Montana.

The policy responses have been incredibly forceful and provided a necessary bridge through this voluntary economic shutdown as we deal with these conditions created by the pandemic, Northey said.

The near-doubling of online sales in the second quarter helped Walmart Inc trounce Wall Street expectations for quarterly profit and same-store sales.

The S&P slumped to a pandemic low on March 23 and has surged about 55% since then, making the bear market that started in late February the benchmark indexs shortest in history.

The S&P 500 gained 0.23%, led by Amazon.com and the Nasdaq Composite added 0.73%. The Dow Jones Industrial Average fell 0.24%.

In Europe, the broad FTSEurofirst 300 index closed down 0.52% at 1,424.85. MSCIs world equity index of equity markets in 49 nations rose 1.65 points or 0.29%, to 573.53.

(Graphic: S&P 500 PE revisits dot-com highs here)

Gold rose more than 1% to climb back above the $2,000 level breached earlier this month, as the dollar fell against a basket of major currencies for a fifth consecutive trading day, under pressure from low yields and mostly bleak U.S. economic data.

The Feds intervention in financial markets to maintain liquidity in the midst of the coronavirus pandemic has weakened the dollar, pushed risk assets to all-time highs and reduced demand for safe-havens.

The dollar index fell 0.551%, with the euro up 0.53% to $1.1932. The Japanese yen strengthened 0.60% versus the greenback to 105.38 per dollar.

Spot gold prices rose 0.74% to $2,000.19 an ounce. U.S. gold futures settled up 0.7% at $2,013.10.

U.S. housing starts jumped 22.6% in July in the latest sign homebuilding is emerging as one of the few areas of strength in an economy suffering a record slowdown because of the pandemic.

U.S. Treasury yields slid as the market largely snubbed the strong housing data and looked for signs that a political stalemate in Washington over a round of aid was easing.

The benchmark 10-year Treasury note fell 1.8 basis points to yield 0.6655%.

Oil prices settled modestly higher in choppy trade. Brent crude futures rose 9 cents to settle at $45.46 a barrel. U.S. crude futures settled unchanged at $42.89 a barrel.

Reporting by Herbert Lash, additional reporting by Stephen Culp in New York and Medha Singh in Bengaluru.; Editing by Nick Zieminski and Andrea Ricci

See more here:
Stocks rally on new U.S. highs, dollar at two-year low - Reuters

Read More...

Coronavirus may have come from bats; could they also hold clues to treatments? – Health24

August 19th, 2020 2:53 pm

Bats have been blamed as a possible source of the new coronavirus pandemic ravaging the globe. But they might also point to possible ways out of it.

Scientists say the winged mammals' immune systems may offer clues on how to fight the new coronavirus and other dangerous viruses in humans.

"Humans have two possible strategies if we want to prevent inflammation, live longer and avoid the deadly effects of diseases like Covid-19," explained study lead author Vera Gorbunova, a professor of biology at the University of Rochester in New York. "One would be to not be exposed to any viruses, but that's not practical. The second would be to regulate our immune system more like a bat."

Resistance and longevity

Many deadly viruses that affect people are believed to have originated in bats, including rabies, Ebola and SARS-CoV-2, the strain that causes Covid-19. But bats have evolved a secret weapon: They're better able to tolerate viruses than humans and other mammals.

"We've been interested in longevity and disease resistance in bats for a while, but we didn't have the time to sit and think about it," Gorbunova said in a university news release.

"Being in quarantine gave us time to discuss this, and we realised there may be a very strong connection between bats' resistance to infectious diseases and their longevity. We also realised that bats can provide clues to human therapies used to fight diseases," she explained.

Typically, a species' lifespan is associated with its body size. The smaller a species, the shorter its lifespan. But many bat species have lifespans of 30 to 40 years, which is impressive for their size, the authors noted in a review article published recently in Cell Metabolism.

Bats' longevity and tolerance to viruses may be due to their ability to control inflammation, which is involved in both ageing and disease. Viruses, including Covid-19, can trigger inflammation.

Our bodies overreact

With Covid-19, this inflammatory response goes "haywire", Gorbunova said. In fact, in many cases it is the inflammatory response that kills the patient, more so than the virus itself.

"The human immune system works like that: Once we get infected, our body sounds an alarm and we develop a fever and inflammation. The goal is to kill the virus and fight infection, but it can also be a detrimental response as our bodies overreact to the threat," Gorbunova said.

In contrast, bats' immune systems control viruses without mounting a strong inflammatory response.

There are several possible reasons why bats evolved to fight viruses and live long lives. Flight may be one of them, the researchers noted.

Constant exposure to viruses

Bats are the only mammals that can fly, which required them to adapt to rapid increases in body temperature, sudden surges in metabolism and molecular damage. These adaptations may also assist in disease resistance, the study authors suggested.

Another factor is that many species of bats live in large, dense colonies, and hang close together on cave ceilings or in trees. Those conditions are ideal for transmitting viruses and other pathogens.

According to Andrei Seluanov, a biology professor at the University of Rochester, "Bats are constantly exposed to viruses. They are always flying out and bringing back something new to the cave or nest, and they transfer the virus because they live in such close proximity to each other."

This means that bats' immune systems are continuously adapting to deal with new viruses. Studying bats' immune systems could lead to new ways to fight aging and diseases in humans, the researchers said.

Image credit: Igam Ogam, Unsplash

See the rest here:
Coronavirus may have come from bats; could they also hold clues to treatments? - Health24

Read More...

The coronavirus is mutating and that could be a very good thing, says infectious disease expert | TheHill – The Hill

August 19th, 2020 2:53 pm

Following the emergence of COVID-19 out of Wuhan, China, late last year, scientists as early as February discovered a slight mutation of the coronavirus that has now become a more predominant variant in Europe and North America andwas recently found in parts of Asia.

While the World Health Organization has said there is no evidence the D614G mutation has led to more harmful cases of COVID-19, theres been some research indicating it may be much more infectious than the strain that first appeared in China.

America is changing FASTER THAN EVER. Add Changing America to yourFacebookandTwitterfeeds to stay engaged on the latest news and smartest insights.

A prominent infectious disease expert says a more infectious strain may actually be a good thing.

Maybe thats a good thing to have a virus that is more infectious but less deadly, Paul Tambyah, senior consultant at the National University of Singapore and president-elect of the International Society of Infectious Diseases, told Reuters in an interview.

Tambyah told the news outlet theres evidence the D614G mutation is less lethal as the increase in the strain in some parts of the world has coincided with a drop in death rates. He noted that most viruses tend to become less virulent as they mutate.

It is in the virus interest to infect more people but not to kill them because a virus depends on the host for food and for shelter, Tambyah told Reuters.

The strain was found recently in a Malaysian cluster of 45 cases that stemmed from someone who returned from India and breached a 14-day home quarantine, prompting authorities there to urge people to take greater precautions.

Malaysias Director-General of health Noor Hisham Abdullah on Sunday made the claim the D614G strain detected in the country was 10 times more infectious and may mean existing studies on vaccines may be incomplete or ineffective against the mutation.

Recent research, however, suggests the mutation is unlikely to have a majoreffect on the efficacy of vaccines currently being developed.

Public health experts who spoke with Reuters agreed.

(The) variants are almost identical and did not change areas that our immune system typically [recognize], so there shouldnt be any difference for vaccines being developed, Sebastian Maurer-Stroh of Singapores agency for science, technology and research told Reuters.

Continue reading here:
The coronavirus is mutating and that could be a very good thing, says infectious disease expert | TheHill - The Hill

Read More...

The mathematics of evolution – Pursuit

August 19th, 2020 2:53 pm

Every so often you think about a moment, and this sounds quite cliched, but its a moment that changed your life, but you didnt realise that it did. For me one of those moments was in year 10. Prior to that year, I was a bit cheeky at school. I was always getting into trouble and I wasnt that interested. And I think it was because I was bored, really.

I had the option to move up into the advanced maths class, but my teacher at the time said all sorts of ridiculous rabble, like people like me dont do maths, so I would struggle if I moved up. Because I am very head strong, I essentially told her to go get stuffed and moved up anyway. And because Im very competitive, I made it my goal to beat everyone in the class and I did that too.

I went to Oxford University and started investigating the evolution of sleep. Sleep as a behaviour, when you think about it from an evolutionary standpoint, makes very little sense. Why would such a vulnerable state evolve?

I submitted a paper, focusing on sleep, and one of the reviewers made a very good point; how do we distinguish sleep from rest? We need to talk about information collection if were to make that distinction. That then led me to thinking about how and when organisms are collecting information about their environment and when theyre not.

Have you heard of the grandmother hypothesis? I went on to look at the evolution of post-menopausal longevity. The grandmother hypothesis posits that post-menopausal grandmothers may increase the reproductive success in their children, and so indirectly their own fitness.

Read more

But significant post-menopausal representation (as opposed to viability) exist only in us humans and the toothed whales. I used a lot of game theory to show that in fact there are some very good reasons why you would expect it to be rare. Now, Im asking other questions, because while I really quite like the grandmother hypothesis I think its very elegant its also very hard to test.

So, for example, if grandmothering is so great, at what point do the benefits of it stop, in terms of increasing life span.

I moved from Oxford to Melbourne to be closer to family. Even just being in the same time zone as my family made a really big difference. Im on a McKenzie Fellowship which gives you an uncommon amount of freedom, for a young academic.

Mathematics can tell us a lot about the world and behaviours. There are famous studies from the 90s investigating the motivations of behaviour around risk. Say you give a bird two options it may be water with different amounts of sugar in it or it may be food. On average, the reward is the same, but the variances are different. If I starve the bird, will the bird go for the more risky option? If I make sure the bird has full energy reserves, will they be more conservative?

We need to reassess the classic studies of behaviour, because they mostly assume that the experimentalists and the experimental subject had the same frame of reference. But I would argue that in most cases, thats not true. I was able to show using some very simple mathematics that we need to be really cautious about the conclusions we draw from those experiments. You can show that, in a finite period of time, they will never agree that the expected rewards are the same.

My work now is looking at traditional Indigenous marriage rules. These are rules for who can marry whom; Im thinking about the mathematics of these rules and the evolutionary consequences of them. One reason Im interested is for very personal reasons, because it is my culture. And I strongly believe we must be keepers of our own knowledge.

Read more

But the other reason is that at the turn of the last century a lot of people were studying these rules, but they were sort of swept aside as cultural artifacts, not having much utility or reasoning behind them.

Indigenous marriage rules are actually quite clever systems to prevent a lot of diseases from spreading. I can show, just with pen-and-paper mathematics, that by following the marriage rules, the entire population of the Gamilaraay Nation (where Im from) which extends from New South Wales to southern Queensland would have to reduce to 24 individuals for people to be as closely related as first cousins when marrying. Thats 24 people, over a landmass that is the size of France.

In the 1850s, the upper crust in England were doing this on purpose. Charles Darwin married his first cousin.

I would argue that this is science. Although Indigenous marriage rules may not be couched in modern scientific terms, to understand these things is to very closely observe, using intense longitudinal studies. This is science.

There are only around five Indigenous mathematicians in the country, and most of them have left academia because of racism. I decided to apply to the ABCs Top 5 Media Residency Program because Im hoping that being a little more visible might encourage other black people to dive into maths.

There are very few of us out here saying Im a black mathematician or Im a black scientist. I think, maybe, thats because we need reminding that not only are we capable, but weve always been capable.

- As told to Dr Daryl Holland

See more here:
The mathematics of evolution - Pursuit

Read More...

City of Corbin to hire lawyer in annexation fight with London – ABC 36 News – WTVQ

August 18th, 2020 9:01 am

CORBIN, Ky. (WTVQ) The Corbin City Commission voted unanimously Monday to hire an attorney in an annexation fight with the City of London, according to a report in The News Journal.

The report says the commission approved a motion to hire lawyer Patrick Hughes.

The area in question is along the West Cumberland Gap Parkway. It is not within the Corbin city limits, but the city installed the water and sewer lines that service that area, according to the report.

The City of London would be required to get permission from the City of Corbin to annex over its existing infrastructure, according to The News Journal.

Corbin cant annex the area because state law only permits a city to annex in a county where it is chartered, according to the report.

Attempts by state lawmakers to amend the existing law that would allow Corbin to annex the area have been unsuccessful, according to The News Journal.

Tom Kenny joined ABC 36 News in June of 2001 as a General Assignment Reporter. A native of Peoria, Illinois, he graduated cum laude with a Bachelor of Arts in Mass Communications from Western Illinois University. He currently anchors ABC 36 News at 5pm, 6pm and 11pm.Tom has more than three decades of experience in broadcast journalism. He is the only broadcast journalist in Lexington television history to be honored with a national Edward R. Murrow Award. Tom was recognized for reporting on a story that gave a rare glimpse inside the secretive world of the Federal Witness Protection Program. He has won an Emmy Award for anchoring and another for investigative reporting, exposing the deceit and potential danger of online diploma mills.Tom has ten other Emmy nominations to his credit for investigative and feature reporting. He has won Associated Press Awards for reporting and anchoring. He has won two Addy Awards for excellence in promotional writing. Tom was the first broadcast journalist in Lexington TV history to be awarded the Silver Circle Award by the National Academy of Television Arts and Sciences. It is one of the highest honors given by NATAS. It recognizes television professionals who have performed distinguished service within the television industry for 25-years or more. Tom was honored for more than his longevity, he was recognized for making an enduring contribution to the vitality of the television industry and for setting high standards of achievement. He was also recognized for giving back to the community as a mentor, educator and volunteer. Tom also has network broadcast experience in radio and television having worked as a sports reporter for ESPN, Sportschannel, NBC Sports and the Breeders Cup. He was also the studio host and halftime producer for CBS Radio Sports College Football Game of the Week and covered the NFL for One-On-One Radio Sports.Prior to joining WTVQ-TV, Tom was Vice-President of the Houston Astros Minor League baseball team in Lexington. He was part of the original management team that brought professional baseball back to the Bluegrass after a nearly 50-year absence.Tom has lived in Lexington since 1984. In that time, he has been heavily involved with dozens of charity and civic groups, with a special emphasis on helping Veterans. He can be reached at tkenny@wtvq.com. You can also follow Tom on Facebook http://www.facebook.com/TomKennyABC and Twitter @TomKennyNews. Just click on the links at the top of the page.

Continued here:
City of Corbin to hire lawyer in annexation fight with London - ABC 36 News - WTVQ

Read More...

RUSSELL GLOOR: Ask Rusty – About the virtues of claiming benefits early – Houston Chronicle

August 18th, 2020 9:01 am

Dear Rusty: It seems like we are always encouraged to wait until our full retirement age or age 70 to claim our Social Security. For me, benefits at age 62 were a good jump start to my retirement. How about listing the many benefits to early (age 62) retirement? And at what age does it become a liability, if ever? Signed: Happily Retired at age 78

Dear Happily Retired:

Youre correct that most financial advisors and Social Security advisors, including me, frequently encourage people to delay claiming Social Security until at least their full retirement age (FRA). And thats because far too many claim their benefits as soon as they are available at age 62 because its there, without evaluating whether thats a smart move for them personally. There are many reasons why its best to wait, but there are also some very good reasons for claiming benefits at age 62. Lets explore those.

Claiming at age 62 is exactly the right move if you are in poor health and dont expect to live a long life. Benefits taken age 62 are 25 percent less for those with a full retirement age (FRA) of 66, and 30 percent less if your FRA is 67. But those reductions become insignificant if you dont expect to live a long, healthy life from that point forward. If you wait until your FRA, it takes about 12 years to collect the same amount in total benefits as if you had claimed at age 62.

Even if you are in decent health now, if your family history and your lifestyle suggest less than average longevity, claiming before your FRA, as early as 62, may be a prudent choice. By lifestyle I mean, for example, whether you exercise regularly, smoke or drink excessively or drive without a seatbelt. There are several life expectancy calculators available which can assist with predicting your life expectancy by evaluating your family history and lifestyle, including those available at this website: https://socialsecurityreport.org/tools/life-expectancy-calculator. Just remember that no one can accurately forecast how long they will live but making an informed decision on when to claim should consider your estimated longevity, among other things.

If collecting your Social Security benefits early is needed to help pay for lifes necessities, such as food, housing, and out-of-pocket medical costs, then claiming as early as age 62, or any other time before your FRA, could be exactly the right choice. In other words, the need for the money now is a driving force in deciding when to claim.

Which brings me to your point that claiming at age 62 was a jump start to your retirement, allowing you to begin enjoying your golden years much earlier than you might have otherwise been able to. Theres a lot to be said for taking benefits early to fulfill your bucket list while youre still young enough to enjoy it. And, from your signature, it looks like youve been putting that extra Social Security money to good use for many years now. Good for you! Now, at age 78, youve reached your breakeven point where, if you had waited until your FRA to claim, your cumulative lifetime benefits would hereafter be more than they will be because you claimed at 62. That may not, however, offset the many years of happy retirement youve been able to enjoy because you took your benefits early.

In the end, deciding when to claim Social Security should be done after carefully evaluating your personal situation. Anyone who claims benefits before their full retirement age must beware of Social Securitys earnings test which limits how much you can earn before your benefits are affected. But those who can afford to wait and who expect to live to a ripe old age would do well to consider delaying until their full retirement age, or even beyond, to claim their Social Security benefits. If their life expectancy is at least average theyll collect much more in cumulative lifetime benefits by doing so.

Russell Gloor is a certified Social Security advisor with the Association of Mature American Citizens.

Read more:
RUSSELL GLOOR: Ask Rusty - About the virtues of claiming benefits early - Houston Chronicle

Read More...

Increase in wastewater rates to get first reading – York News-Times

August 18th, 2020 9:01 am

YORK A proposed 9 percent increase in wastewater rates is being proposed for the City of York and the first reading of an ordinance that would enact that increase will be held this coming Thursday.

Earlier, it was proposed that a higher rate increase would be needed, but then later determined that a smaller increase would be sufficient.

The increase is attributed to the citys large project of building a new wastewater treatment plant and installing all the infrastructure that goes a long with it.

The good news is that no rate increases are being proposed this year for water or for the landfill.

Also on Thursday night, during the city councils regular meeting, the following will be discussed:

A second reading of an ordinance addressing longevity pay for employees will be held. Getting rid of or altering the citys longevity pay program has come and gone over the past few years, only to come back again.

The council will consider the sale of a small piece of land to Matt and Lynn Leif, for $1,500.

The council will also hold a discussion about the budget for the new 2020-21 fiscal year. The council, administration and department heads have been discussing budget issues for quite some time now. Approval is nearing. As the budget looks at this time, there will likely not be any increase of the tax levy and reserves are projected to be more than $2 million when the fiscal year ends.

The public is always encouraged to attend the meeting, which will begin at 7 p.m., in the council chambers, on Thursday, Aug. 20.

Here is the original post:
Increase in wastewater rates to get first reading - York News-Times

Read More...

To Live Longer, Healthier, Avoid Saturated Fat in Meat and Dairy – The Beet

August 18th, 2020 9:01 am

The observation that diet and health are related can be traced back at least to Maimonides a 1,000 years ago and Hippocrates over 2,000 years ago. With advances in public health measures and medical care, the average lifespan has been dramatically extended. Unfortunately, many of the extra years are burdened with chronic diseases, like heart disease and cancer.

More than ever, trying to determine what diet is most related to health is of importance to living a long life without disease. Nutrition science can be difficult, complex, and conflicting at times. What can you do when headlines appear that are in direct conflict with one another? Is the media biased, or even bought?

In the last few months, this situation has exploded, and it pertains to the role of whole food plant diets and heart disease. Research on the contribution of foods rich in saturated fats like cheese, butter, meats, eggs, and pastries to heart disease has been ongoing since the 1950s. In order to evaluate the most current and quality data, a systematic review and meta-analysis of the relationship between saturated fat and heart disease were published by the Cochrane Database of Systematic Reviews (CDSR)in May. The CDSR is widely regarded as the leading and most respected of sources for evaluating topics in health care.

The authors analyzed 15 controlled trials involving over 59,000 subjects and concluded that The findings of this updated review suggest that reducing saturated fat intake for at least two years causes a potentially important reduction in combined cardiovascular events (21%). Replacing the energy from saturated fat with polyunsaturated fat or carbohydrate appears to be useful strategies. It would seem clear that reducing or eliminating meats, cheeses, egg yolks, lard, butter, ghee and baked goods would favor better odds of avoiding heart disease. Of note, major media channels did not report on this research and it was buried in the National Library of Medicine.

The clarity on nutrition advice provided by the esteemed CDSR lasted all of 3-4 weeks as a State of the Art Review by 12 authors on the topic of saturated fat and health was published in a major cardiology journal on June 16, 2020. They did not conduct original research but analyzed previously published studies. The 12 authors concluded that Whole-fat dairy, unprocessed meat, eggs and dark chocolate are SFA-rich foods with a complex matrix that are not associated with increased risk of CVD. The totality of available evidence does not support further limiting the intake of such foods. Unlike the esteemed CDSR paper, this review created 100s of headlines worldwide.

How can we reconcile such conflicting conclusions? It is challenging and leaves many confused, feeling that they can eat whatever they want while nutrition scientists duke it out. One major concern not mentioned in the media regarding the 2nd paper promoting saturated fat was that 9 of the 12 authors disclosed research funding by dairy or beef foundations. Lets repeat that: 75% of the authors promoting saturated fat were funded by industry organizations that promote foods rich in saturated fat!

In a second challenge to the findings of the CDSR, 10 authors published a hypothesis that those suffering from a relatively rare genetic disorder causing high cholesterol, familial hyperlipidemia, would benefit more from a low-carbohydrate diet than a low-fat diet. The authors did not conduct original research. Guess what? Five of the 10 authors revealed financial ties that they benefit from relating to low-carb diets. The other 5 are well known low-carb advocates routinely advocating for dietary approaches in conflict with major medical societies and research findings. Would you be surprised that this paper also got worldwide headlines indicating that a new paradigm had been identified?

Are there any ways to approach nutrition research with a system you can digest when new data and conflicting reports appear? I rely on two leading research scientists who have proposed such an approach:One is Valter Longo, Ph.D., author of The Longevity Diet, creator of the plant-based Fasting Mimicking Diet, and internationally known leading academic researcher.

Dr. Longo describes the Five Pillars of Longevity as a format to evaluated nutrition research. These 5 pillars are:1) biochemical research, 2) randomized trials, 3) epidemiology, 4) study of centenarians, and finally, 5) analysis of complex systems (like the environmental impact of diet). For example, Dr. Longo considers the popular keto diet to bea half a pillar at most as it lacks many of the components of this analytical system. In contrast, Dr. Longo teaches a plant-based diet in his book as it encompasses all 5 pillars.

The other leading scientist is Nobel Prize Laureate Michael Brown, MD who was awarded this high honor in 1985 for his research on the LDL cholesterol.Dr. Brown delivered a lecture titled A Century of Cholesterol and Coronaries and described a method of evaluating the scientific literature on the relationship between cholesterol and heart disease. He called the method the Four Lines of Evidence. These 4 lines were remarkably similar to the Pillars described by Dr. Longo. Together they provide a framework to consider new information in a meaningful and big picture way.

What can be concluded regarding saturated fat and heart disease? Should you add butter to your coffee tomorrow? One study was published by an esteemed organization (CDSR). The other two were written by authors with major financial biases, including investments in companies dedicated to promoting diets high in saturated fats.

Using the 5 Pillars or the 4 Lines of Evidence, there exists biochemistry, randomized trials, epidemiology, and Centenarian data that indicate that diets lower in saturated fats (reduced or absent meats, cheeses, butter, pastries, lard, ghee) promote health and reduce the risk of heart disease. No single new study can up-end 70 years of research, even if a new study can get inordinate and inappropriate praise in the media. While nutrition science can be challenging, using the methods here as a guidepost to the research you believe will help you make healthy decisions about your diet. One simple rule: Always favor plant-based selections. Do not believe all media headlines. They can be bought or, at a minimum, influenced, by a flow of dollars that generates clickbait headlines.

More here:
To Live Longer, Healthier, Avoid Saturated Fat in Meat and Dairy - The Beet

Read More...

DC Universe original TV shows will move to HBO Max – Business Insider Australia

August 18th, 2020 9:01 am

Speculation intensified about the future of the fan-centric DC Universe streaming service after DC was hit with massive layoffs on Monday as part of a larger restructuring for its parent company, WarnerMedia. The majority of the DCU staff was laid off, according to The Hollywood Reporter.

In an interview with THR addressing the layoffs on Friday, DC publisher and creative chief Jim Lee said that the original content that is on DCU is migrating to HBO Max, confirming that DCUs original TV shows will move to WarnerMedias new flagship streaming platform that launched in May.

Truthfully, thats the best platform for that content, Lee told THR. The amount of content you get, not just DC, but generally from WarnerMedia, is huge and its the best value proposition if Im allowed to use that marketing term. We feel that is the place for that.

DCUs Doom Patrol and Harley Quinn are already streaming on Max. Another DC Universe original, Stargirl, was renewed last month for a second season exclusively on The CW network.

But the writing has been on the wall for months regarding DCUs originals. Last year, DCU abruptly cancelled its original series Swamp Thing after one season, shocking crewmembers. In May, ahead of Maxs launch, Business Insider reported that WarnerMedia wasnt prioritising DCU. People close to the service questioned its longevity.

Everything is about HBO Max now, said a former employee of Warner Bros. Digital Labs, a product unit that works with the companys streaming services.

And in an interview in May, Maxs former content chief Kevin Reilly who was fired this month as part of the WarnerMedia shakeup told Business Insider that there had been extensive discussions around DCU because DC is such a valuable entity to us and the depth of fandom is so important.

DCU shows wont be the only original DC content on Max. The streamer is developing its own DC originals, including a Green Lantern spinoff of next years The Batman movie about the Gotham City police. Reilly told Business Insider that fans should expect the highest level of cinematic production values on the shows.

While DCUs original content will be leaving the service, Lee told THR that its definitely not going away. The service also serves as a community hub for fans and offers a library of digital comics.

In regards to the community and experience that DCU created, and all the backlist content, something like 20,000 to 25,000 different titles, and the way it connected with fans 24-7, there is always going to be a need for that, Lee said. So were excited to transform it and well have more news on what that will look like.

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.

Follow this link:
DC Universe original TV shows will move to HBO Max - Business Insider Australia

Read More...

Viewpoint: Is there a scientific basis to ban gene drive technology that can rid us of virus-carrying rodents and mosquitoes? – Genetic Literacy…

August 18th, 2020 9:00 am

Gene drives may be invaluable tools to control the spread of parasites, invasive species, and disease carriers. But the technology has faced strong opposition from activist groups and some mainstream scientists based on environmental and food safety. Are these concerns valid?

On June 30, some 80 environmental organizations, led by Greenpeace EU, Friends of the Earth Europe and Save Our Seeds, signed an open letter to the European Commission asking for support for a global moratorium on gene drive technology. The advocacy groups claimed that the release of gene drives poses serious and novel threats to biodiversity and the environment at an unprecedented scale and depth.

Citing a report by the European Network of Scientists for Social and Environmental Responsibility (ENSSER), the coalition wrote:

in light of the unpredictabilities, the lack of knowledge and the potentially severe negative impacts on biodiversity and ecosystems, any releases (including experimental) of Gene Drive Organisms into the environment be placed on hold to allow proper investigation until there is sufficient knowledge and understanding.

The environmental claims were unsupported by any documents other than the report by ENSSER, a controversial group of anti-biotechnology activist scientists co-founded by Gilles-ricSralini, best known for his retracted and discredited 2012 paper linking GMOs to cancer in rats.

The European parliament has already supported such a moratorium, an act that echoes EUs precautionary approach to genetic engineering, transgenic organisms and gene editing. The EU stated reasons include:

Recent advances in genetics and synthetic biology, particularly the development of CRISPR gene editing tools, have given scientists a powerful way to address problems created by pests, from mosquitoes to rodents, that vector disease to humans. In classical genetics, genes that offer adaptation benefits to individuals tend to increase their occurrence in the population while genes that reduce fitness tend to disappear.

Gene drives are genetic sequences designed to spread strongly and become present in every individual of a targeted species after a few generations. The genes may offer benefits, be neutral for adaptation purposes, or hinder their carriers survival and reproduction potential.Generation after generation, it would relentlessly copy and paste the gene it carried, until the gene and the desired trait was present in every descendant.Because the spread of a trait happens over generations, a gene drive works best in species that reproduce quickly, like insects and rodents

Gene drives are the first genetic constructs that can theoretically affect a population in its entirety, and quickly. It could even lead to the extinction of entire species, as gene drive critics allege. Species distinction has been part of life and evolution for all of Earths history. Although the data are fuzzy and contested, the UN Convention on Biological Diversity concluded that 150-200 plant, insect bird, and mammal species go extinct every day.

The likelihood that a gene drive will destroy a species in part or in whole, such as the infectedAedes aegyptimosquito species that carries the Zika, dengue and chingunya viruses and offers no known environmental benefits, is nonetheless daunting to some. On the one hand, gene drives could be used to eradicate disease such as malaria and yellow fever by controlling the mosquitoes that transmit them. On the other hand, critics fear that the technology will open a Pandoras Box; removing a species that theoretically could resultin what is popularly and controversially known as the butterfly effect.

As imagined by MIT meteorologist Edward Lorenz 60 years ago, a tiny environmental changesay an extinction of a pestcould dramatically and unpredictably result in unpredictable or even catastrophic consequences (Lorenz imagined abutterflyflapping its wings and causing a typhoon).

In the last few years, various groups have called for a global moratorium on gene drives. Such attempts were resisted at the 2016 and 2018 United Nations Conventions on Biological Diversity, mainly due to the strong opposition of many scientists and sub-Saharan African nations hardest hit by disease-vectored pests. Nevertheless, gene drive opponents have gained traction and gene drive research and applications face significant regulatory obstacles across the world (see Genetic Literacys Global Gene Editing Regulation tracker for a country-by-country analysis).

What does the scientific evidence say about gene drives and their environmental consequences?

There are over 3,000 mosquito species, likely a fraction of the number of species that have existed over some 100 million years. A handful of these (Aedes, Anopheles, and Culex species) are disease vectors and transmit infections such as malaria, yellow fever, the West Nile virus, Zika, and dengue fever. Mosquito-borne disease account for more than 17% of all infectious diseases and cause more than 700,000 deaths every year. These mosquitoes are mostly invasive in their ecological distributions.

Ultimately, there seem to be few things that mosquitoes do that other organisms cant do just as wellexcept perhaps for one, reported Nature magazine ina 2010 article A World Without Mosquitoes.

They are lethally efficient at sucking blood from one individual and mainlining it into another, providing an ideal route for the spread of pathogenic microbes. The Nature article concluded that wiping out mosquitoes wouldnt be a badthing. In fact, they could restore rather than harm the ecosystem. The same can be inferred for most parasitic insects, which are specialized to a particular host and normally dont have an extended ecological interactions network.

Invasive species also cause significant environmental hazards. Cane toads, having no natural predators, are slowly taking over the Australian continent from the northeast. Invasive fish from the red sea are wrecking havoc in the Mediterranean marine ecosystems. Rodents have spread in every conceivable corner of the earth, displacing vulnerable local fauna.

Gene drives might be one of the only ways to contain their spread, protecting biodiversity. They can be a powerful conservation tool that targets only the organism of interest, unlike contemporary pest management techniques such as the use of insecticides that attack all insects indiscriminately, or introduction of natural predators from other ecosystems (that by default disturb the food chains and interactions network).

It is possible for a DNA sequence to jump from one species to the other through a process called horizontal gene transfer. This theoretically could happen between insects, which appears to lend support to the argument that there is at least a small chance for a gene drive to move from species to species with unforeseen consequences.

The truth is that gene drives can be designed to target a very specific area of the genome, unique for a species. The modern gene drives use the precise CRISPR base editing technologies to spread to the population. In the off chance that the DNA encoding the gene drive will enter the reproductive cells of an individual from the other species, the editing system will have no template to act upon and the gene will be lost. One may argue that CRISPR has a chance for off-target activity, but a gene drive needs maximum efficiency to act as a gene drive. If the CRISPR doesnt work at 100%, the DNA sequence will be subject to the typical laws of inheritance and will disappear from the genetic pool

The ability to introduce genetic information to a wild population, which will spread to every individual, is unfortunately a dual use technology. The technology can theoretically be exploited to make biological weapons, though theres no indication that such a weapon is or has been developed. As gene drives can work well across many generations and require a large amount of offspring, they are unable to directly harm humans, crops, and farm animals. But a gene drive could be used to enhance the fitness of a crop-eating insect or a disease-carrying rodent.

The solution to this potential hazard is more research (and definitely not a research moratorium). Anyone with the means (which are considerable, so no lone bioterrorists or rogue scientists) and intent to cause harm can already research into such applications and will ignore aUN-imposed technology ban. The research community needs to develop the means to detect and monitor any malicious gene drive release and counter any offensive use.

The question on who and how should approve gene drive projects isnt easy to answer. A gene drive isnt contained by country borders, and the outdated GMO regulation framework existing in most countries is scientifically outdated and practically inadequate to handle such applications.

Moreover, the technology cannot be monopolized by a few countries or private companies. Each project is different. The approval should be a result of consensus among numerous stakeholders. There should also be a defined way to monitor how the gene drive spreads and how to handle liability claims if there are negative effects.

With populism growing and fewer people willing to trust the judgment of regulators and scientists, the rhetoric around complex innovations has become increasingly polarized, with both sides stuck fighting a high-stakes battle for public opinion. The issue is complex, and any decisions cannot be left to scientists, state organizations, and companies alone. But it also cannot be left solely in the hands of environmental organizations with little or no understanding of the science and with an ideological agenda that doesnt necessarily serve the public.

Environmental groups have often resorted to hyperbole as the debate over gene drives has unfolded. At the UN Convention on Biological Diversity in Sharm el Sheikh, Egypt, in 2018, a coalition of activists compared gene drives to the atomic bomb and accused researchers of using malaria as a Trojan horse to cover up the development of agricultural gene drives for corporate profit.A handful of small NGOs in the US, collectively known as SynBioWatch, have taken to describing gene-drive researchers as a cabal. The Canadian anti-biotechnology organization ETC Group claims aggressively spreads misinformation on social media, including claims that gene-drive honeybees could supposedly be controlled with a beam of light.

Meanwhile, Florida Keys is experiencing the largest dengue fever outbreak in a decade, with close to 40 cases already documented. The outbreak has led the Florida Keys Mosquito Control District to enter a partnership with UK-based, US-owned Oxitec that could lead to the Keys becoming the first U.S. trial site for genetically modified Aedes aegypti mosquitoes.

With a technology that can prevent hundreds of thousands of deaths per year, it is unethical to peremptorily ban it because it doesnt fit a few peoples worldview of what is natural. One may argue that governments and regulators should have no say whether one species should go extinct or not. But one can also question why activist groups in North America or Europe should be able to insert themselves in life and death decisions, preventing initiatives across the globe that could save millions of lives and protect our populations health and crops, and promote biological diversity.

Kostas Vavitsas, PhD, is a Senior Research Associate at the University of Athens, Greece. He is also a steering committee member of EUSynBioS. Follow him on Twitter@konvavitsas

Excerpt from:
Viewpoint: Is there a scientific basis to ban gene drive technology that can rid us of virus-carrying rodents and mosquitoes? - Genetic Literacy...

Read More...

Biotechnology Could Change the Cattle Industry. Will It Succeed? – Singularity Hub

August 18th, 2020 9:00 am

When Ralph Fisher, a Texas cattle rancher, set eyes on one of the worlds first cloned calves in August 1999, he didnt care what the scientists said: He knew it was his old Brahman bull, Chance, born again. About a year earlier, veterinarians at Texas A&M extracted DNA from one of Chances moles and used the sample to create a genetic double. Chance didnt live to meet his second self, but when the calf was born, Fisher christened him Second Chance, convinced he was the same animal.

Scientists cautioned Fisher that clones are more like twins than carbon copies: The two may act or even look different from one another. But as far as Fisher was concerned, Second Chance was Chance. Not only did they look identical from a certain distance, they behaved the same way as well. They ate with the same odd mannerisms; laid in the same spot in the yard. But in 2003, Second Chance attacked Fisher and tried to gore him with his horns. About 18 months later, the bull tossed Fisher into the air like an inconvenience and rammed him into the fence. Despite 80 stitches and a torn scrotum, Fisher resisted the idea that Second Chance was unlike his tame namesake, telling the radio program This American Life that I forgive him, you know?

In the two decades since Second Chance marked a genetic engineering milestone, cattle have secured a place on the front lines of biotechnology research. Today, scientists around the world are using cutting-edge technologies, from subcutaneous biosensors to specialized food supplements, in an effort to improve safety and efficiency within the $385 billion global cattle meat industry. Beyond boosting profits, their efforts are driven by an imminent climate crisis, in which cattle play a significant role, and growing concern for livestock welfare among consumers.

Gene editing stands out as the most revolutionary of these technologies. Although gene-edited cattle have yet to be granted approval for human consumption, researchers say tools like Crispr-Cas9 could let them improve on conventional breeding practices and create cows that are healthier, meatier, and less detrimental to the environment. Cows are also being given genes from the human immune system to create antibodies in the fight against Covid-19. (The genes of non-bovine livestock such as pigs and goats, meanwhile, have been hacked to grow transplantable human organs and produce cancer drugs in their milk.)

But some experts worry biotech cattle may never make it out of the barn. For one thing, theres the optics issue: Gene editing tends to grab headlines for its role in controversial research and biotech blunders. Crispr-Cas9 is often celebrated for its potential to alter the blueprint of life, but that enormous promise can become a liability in the hands of rogue and unscrupulous researchers, tempting regulatory agencies to toughen restrictions on the technologys use. And its unclear how eager the public will be to buy beef from gene-edited animals. So the question isnt just if the technology will work in developing supercharged cattle, but whether consumers and regulators will support it.

Cattle are catalysts for climate change. Livestock account for an estimated 14.5 percent of greenhouse gas emissions from human activities, of which cattle are responsible for about two thirds, according to the United Nations Food and Agriculture Organization (FAO). One simple way to address the issue is to eat less meat. But meat consumption is expected to increase along with global population and average income. A 2012 report by the FAO projected that meat production will increase by 76 percent by 2050, as beef consumption increases by 1.2 percent annually. And the United States is projected to set a record for beef production in 2021, according to the Department of Agriculture.

For Alison Van Eenennaam, an animal geneticist at the University of California, Davis, part of the answer is creating more efficient cattle that rely on fewer resources. According to Van Eenennaam, the number of dairy cows in the United States decreased from around 25 million in the 1940s to around 9 million in 2007, while milk production has increased by nearly 60 percent. Van Eenennaam credits this boost in productivity to conventional selective breeding.

You dont need to be a rocket scientist or even a mathematician to figure out that the environmental footprint or the greenhouse gases associated with a glass of milk today is about one-third of that associated with a glass of milk in the 1940s, she says. Anything you can do to accelerate the rate of conventional breeding is going to reduce the environmental footprint of a glass of milk or a pound of meat.

Modern gene-editing tools may fuel that acceleration. By making precise cuts to DNA, geneticists insert or remove naturally occurring genes associated with specific traits. Some experts insist that gene editing has the potential to spark a new food revolution.

Jon Oatley, a reproductive biologist at Washington State University, wants to use Crispr-Cas9 to fine tune the genetic code of rugged, disease-resistant, and heat-tolerant bulls that have been bred to thrive on the open range. By disabling a gene called NANOS2, he says he aims to eliminate the capacity for a bull to make his own sperm, turning the recipient into a surrogate for sperm-producing stem cells from more productive prized stock. These surrogate sires, equipped with sperm from prize bulls, would then be released into range herds that are often genetically isolated and difficult to access, and the premium genes would then be transmitted to their offspring.

Furthermore, surrogate sires would enable ranchers to introduce desired traits without having to wrangle their herd into one place for artificial insemination, says Oatley. He envisions the gene-edited bulls serving herds in tropical regions like Brazil, the worlds largest beef exporter and home to around 200 million of the approximately 1.5 billion head of cattle on Earth.

Brazils herds are dominated by Nelore, a hardy breed that lacks the carcass and meat quality of breeds like Angus but can withstand high heat and humidity. Put an Angus bull on a tropical pasture and hes probably going to last maybe a month before he succumbs to the environment, says Oatley, while a Nelore bull carrying Angus sperm would have no problem with the climate.

The goal, according to Oatley, is to introduce genes from beefier bulls into these less efficient herds, increasing their productivity and decreasing their overall impact on the environment. We have shrinking resources, he says, and need new, innovative strategies for making those limited resources last.

Oatley has demonstrated his technique in mice but faces challenges with livestock. For starters, disabling NANOS2 does not definitively prevent the surrogate bull from producing some of its own sperm. And while Oatley has shown he can transplant sperm-producing cells into surrogate livestock, researchers have not yet published evidence showing that the surrogates produce enough quality sperm to support natural fertilization. How many cells will you need to make this bull actually fertile? asks Ina Dobrinski, a reproductive biologist at the University of Calgary who helped pioneer germ cell transplantation in large animals.

But Oatleys greatest challenge may be one shared with others in the bioengineered cattle industry: overcoming regulatory restrictions and societal suspicion. Surrogate sires would be classified as gene-edited animals by the Food and Drug Administration, meaning theyd face a rigorous approval process before their offspring could be sold for human consumption. But Oatley maintains that if his method is successful, the sperm itself would not be gene-edited, nor would the resulting offspring. The only gene-edited specimens would be the surrogate sires, which act like vessels in which the elite sperm travel.

Even so, says Dobrinski, Thats a very detailed difference and Im not sure how that will work with regulatory and consumer acceptance.

In fact, American attitudes towards gene editing have been generally positive when the modification is in the interest of animal welfare. Many dairy farmers prefer hornless cowshorns can inflict damage when wielded by 1,500-pound animalsso they often burn them off in a painful process using corrosive chemicals and scalding irons. In a study published last year in the journal PLOS One, researchers found that most Americans are willing to consume food products from cows genetically modified to be hornless.

Still, experts say several high-profile gene-editing failures in livestock and humans in recent years may lead consumers to consider new biotechnologies to be dangerous and unwieldy.

In 2014, a Minnesota startup called Recombinetics, a company with which Van Eenennaams lab has collaborated, created a pair of cross-bred Holstein bulls using the gene-editing tool TALENs, a precursor to Crispr-Cas9, making cuts to the bovine DNA and altering the genes to prevent the bulls from growing horns. Holstein cattle, which almost always carry horned genes, are highly productive dairy cows, so using conventional breeding to introduce hornless genes from less productive breeds can compromise the Holsteins productivity. Gene editing offered a chance to introduce only the genes Recombinetics wanted. Their hope was to use this experiment to prove that milk from the bulls female progeny was nutritionally equivalent to milk from non-edited stock. Such results could inform future efforts to make Holsteins hornless but no less productive.

The experiment seemed to work. In 2015, Buri and Spotigy were born. Over the next few years, the breakthrough received widespread media coverage, and when Buris hornless descendant graced the cover of Wired magazine in April 2019, it did so as the ostensible face of the livestock industrys future.

But early last year, a bioinformatician at the FDA ran a test on Buris genome and discovered an unexpected sliver of genetic code that didnt belong. Traces of bacterial DNA called a plasmid, which Recombinetics used to edit the bulls genome, had stayed behind in the editing process, carrying genes linked to antibiotic resistance in bacteria. After the agency published its findings, the media reaction was swift and fierce: FDA finds a surprise in gene-edited cattle: antibiotic-resistant, non-bovine DNA, read one headline. Part cow, part bacterium? read another.

Recombinetics has since insisted that the leftover plasmid DNA was likely harmless and stressed that this sort of genetic slipup is not uncommon.

Is there any risk with the plasmid? I would say theres none, says Tad Sonstegard, president and CEO of Acceligen, a Recombinetics subsidiary. We eat plasmids all the time, and were filled with microorganisms in our body that have plasmids. In hindsight, Sonstegard says his teams only mistake was not properly screening for the plasmid to begin with.

While the presence of antibiotic-resistant plasmid genes in beef probably does not pose a direct threat to consumers, according to Jennifer Kuzma, a professor of science and technology policy and co-director of the Genetic Engineering and Society Center at North Carolina State University, it does raise the possible risk of introducing antibiotic-resistant genes into the microflora of peoples digestive systems. Although unlikely, organisms in the gut could integrate those genes into their own DNA and, as a result, proliferate antibiotic resistance, making it more difficult to fight off bacterial diseases.

The lesson that I think is learned there is that science is never 100 percent certain, and that when youre doing a risk assessment, having some humility in your technology product is important, because you never know what youre going to discover further down the road, she says. In the case of Recombinetics. I dont think there was any ill intent on the part of the researchers, but sometimes being very optimistic about your technology and enthusiastic about it causes you to have blinders on when it comes to risk assessment.

The FDA eventually clarified its results, insisting that the study was meant only to publicize the presence of the plasmid, not to suggest the bacterial DNA was necessarily dangerous. Nonetheless, the damage was done. As a result of the blunder,a plan was quashed forRecombinetics to raise an experimental herd in Brazil.

Backlash to the FDA study exposed a fundamental disagreement between the agency and livestock biotechnologists. Scientists like Van Eenennaam, who in 2017 received a $500,000 grant from the Department of Agriculture to study Buris progeny, disagree with the FDAs strict regulatory approach to gene-edited animals. Typical GMOs are transgenic, meaning they have genes from multiple different species, but modern gene-editing techniques allow scientists to stay roughly within the confines of conventional breeding, adding and removing traits that naturally occur within the species. That said, gene editing is not yet free from errors and sometimes intended changes result in unintended alterations, notes Heather Lombardi, division director of animal bioengineering and cellular therapies at the FDAs Center for Veterinary Medicine. For that reason, the FDA remains cautious.

Theres a lot out there that I think is still unknown in terms of unintended consequences associated with using genome-editing technology, says Lombardi. Were just trying to get an understanding of what the potential impact is, if any, on safety.

Bhanu Telugu, an animal scientist at the University of Maryland and president and chief science officer at the agriculture technology startup RenOVAte Biosciences, worries that biotech companies will migrate their experiments to countries with looser regulatory environments. Perhaps more pressingly, he says strict regulation requiring long and expensive approval processes may incentivize these companies to work only on traits that are most profitable, rather than those that may have the greatest benefit for livestock and society, such as animal well-being and the environment.

What company would be willing to spend $20 million on potentially alleviating heat stress at this point? he asks.

On a windy winter afternoon, Raluca Mateescu leaned against a fence post at the University of Floridas Beef Teaching Unit while a Brahman heifer sniffed inquisitively at the air and reached out its tongue in search of unseen food. Since 2017, Mateescu, an animal geneticist at the university, has been part of a team studying heat and humidity tolerance in breeds like Brahman and Brangus (a mix between Brahman and Angus cattle). Her aim is to identify the genetic markers that contribute to a breeds climate resilience, markers that might lead to more precise breeding and gene-editing practices.

In the South, Mateescu says, heat and humidity are a major problem. That poses a stress to the animals because theyre selected for intense productionto produce milk or grow fast and produce a lot of muscle and fat.

Like Nelore cattle in South America, Brahman are well-suited for tropical and subtropical climates, but their high tolerance for heat and humidity comes at the cost of lower meat quality than other breeds. Mateescu and her team have examined skin biopsies and found that relatively large sweat glands allow Brahman to better regulate their internal body temperature. With funding from the USDAs National Institute of Food and Agriculture, the researchers now plan to identify specific genetic markers that correlate with tolerance to tropical conditions.

If were selecting for animals that produce more without having a way to cool off, were going to run into trouble, she says.

There are other avenues in biotechnology beyond gene editing that may help reduce the cattle industrys footprint. Although still early in their development, lab-cultured meats may someday undermine todays beef producers by offering consumers an affordable alternative to the conventionally grown product, without the animal welfare and environmental concerns that arise from eating beef harvested from a carcass.

Other biotech techniques hope to improve the beef industry without displacing it. In Switzerland, scientists at a startup called Mootral are experimenting with a garlic-based food supplement designed to alter the bovine digestive makeup to reduce the amount of methane they emit. Studies have shown the product to reduce methane emissions by about 20 percent in meat cattle, according to the New York Times.

In order to adhere to the Paris climate agreement, Mootrals owner, Thomas Hafner, believes demand will grow as governments require methane reductions from their livestock producers. We are working from the assumption that down the line every cow will be regulated to be on a methane reducer, he told the New York Times.

Meanwhile, a farm science research institute in New Zealand, AgResearch, hopes to target methane production at its source by eliminating methanogens, the microbes thought to be responsible for producing the greenhouse gas in ruminants. The AgResearch team is attempting to develop a vaccine to alter the cattle guts microbial composition, according to the BBC.

Genomic testing may also allow cattle producers to see what genes calves carry before theyre born, according to Mateescu, enabling producers to make smarter breeding decisions and select for the most desirable traits, whether it be heat tolerance, disease resistance, or carcass weight.

Despite all these efforts, questions remain as to whether biotech can ever dramatically reduce the industrys emissions or afford humane treatment to captive animals in resource-intensive operations. To many of the industrys critics, including environmental and animal rights activists, the very nature of the practice of rearing livestock for human consumption erodes the noble goal of sustainable food production. Rather than revamp the industry, these critics suggest alternatives such as meat-free diets to fulfill our need for protein. Indeed, data suggests many young consumers are already incorporating plant-based meats into their meals.

Ultimately, though, climate change may be the most pressing issue facing the cattle industry, according to Telugu of the University of Maryland, which received a grant from the Bill and Melinda Gates Foundation to improve productivity and adaptability in African cattle. We cannot breed our way out of this, he says.

This article was originally published on Undark. Read the original article.

Image Credit: RitaE from Pixabay

View original post here:
Biotechnology Could Change the Cattle Industry. Will It Succeed? - Singularity Hub

Read More...

Boundless Bio Announces Publication in Nature Genetics Detailing the Association Between Extrachromosomal DNA-Based Oncogene Amplification and Poor…

August 18th, 2020 9:00 am

SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a company developing innovative new therapies directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced research published in the journal Nature Genetics that demonstrates that ecDNA-based oncogene amplification drives poor outcomes for patients across many cancer types.

The manuscript, Frequent extrachromosomal oncogene amplification drives aggressive tumors, was co-authored by Boundless Bio scientists Nam-phuong Nguyen, Ph.D., and Kristen Turner, Ph.D., and scientific founders Paul Mischel, M.D., Distinguished Professor at the University of California San Diego (UC San Diego) School of Medicine and a member of the Ludwig Institute for Cancer Research; Vineet Bafna, Ph.D., Professor of Computer Science & Engineering, UC San Diego; Howard Chang, M.D., Ph.D., Virginia and D.K. Ludwig Professor of Cancer Genomics and Genetics, Stanford University; and Roel Verhaak, Ph.D., Professor and Associate Director of Computational Biology, The Jackson Laboratory.

The researchers used intensive computational analysis of whole-genome sequencing data from more than 3200 tumor samples in The Cancer Genome Atlas (TCGA) and the Pan-Cancer Analysis of Whole Genomes (PCAWG), totaling over 400 TB of raw sequencing data, to observe the impact of ecDNA amplification on patient outcomes. The researchers observed that ecDNA amplification occurs in many types of cancers, but not in normal tissue or in whole blood, and that the most common recurrent oncogene amplifications frequently arise on ecDNA. Notably, ecDNA-based circular amplicons were found in 25 of 29 cancer types analyzed, and at high frequency in many cancers that are considered to be amongst the most aggressive histological types, such as glioblastoma, sarcoma, and esophageal carcinoma. In addition, patients whose cancers carried ecDNA had significantly shorter survival, even when controlled for tissue type, than patients whose cancers were not driven by ecDNA-based oncogene amplification.

The findings demonstrate that ecDNA play a critical role in cancer, providing a mechanism for achieving and maintaining high copy number oncogene amplification and genetic heterogeneity while driving enhanced chromatin accessibility and elevating oncogene transcription. ecDNA amplifications are associated with aggressive cancer behavior, potentially by providing tumors with additional routes to circumvent current treatments and other evolutionary bottlenecks. The shorter overall survival, even when stratified by tumor type, raises the possibility that cancer patients whose tumors are driven by ecDNA may not be as responsive to current therapies and may be in need of new forms of treatment.

This important study builds on our rapidly expanding knowledge about ecDNA, showing, for the first time, that ecDNA amplifications are present in a broad range of cancer tumor types, said Jason Christiansen, Ph.D., Chief Technology Officer of Boundless Bio. These results point to the urgent need for therapies that can target ecDNA and interfere with their ability to drive aggressive cancer growth, resistance, and recurrence.

By detecting and characterizing the role that ecDNA play in driving hard-to-treat cancers, we are drawing a more accurate map of the cancer genome, said Dr. Mischel. It is our goal to take these findings and apply them to the development of powerful anti-cancer therapies for individuals with ecDNA-driven cancers.

About ecDNA

Extrachromosomal DNA, or ecDNA, are distinct circular units of DNA containing functional genes that are located outside cells chromosomes and can make many copies of themselves. ecDNA rapidly replicate within cancer cells, causing high numbers of oncogene copies, a trait that can be passed to daughter cells in asymmetric ways during cell division. Cancer cells have the ability to upregulate or downregulate oncogenes located on ecDNA to ensure survival under selective pressures, including chemotherapy, targeted therapy, immunotherapy, or radiation, making ecDNA one of cancer cells primary mechanisms of recurrence and treatment resistance. ecDNA are rarely seen in healthy cells but are found in many solid tumor cancers. They are a key driver of the most aggressive and difficult-to-treat cancers, specifically those characterized by high copy number amplification of oncogenes.

About Boundless Bio

Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.

For more information, visit http://www.boundlessbio.com.

Follow us on LinkedIn and Twitter.

About Boundless Bios Spyglass Platform

Boundless Bios Spyglass platform is a comprehensive suite of proprietary ecDNA-driven and pair-matched tumor models along with proprietary imaging and molecular analytical tools that enables Boundlesss researchers to interrogate ecDNA biology to identify a pipeline of novel oncotargets essential to the function of cancer cells that are enabled by ecDNA. The Spyglass platform facilitates Boundless innovation in the development of precision therapeutics specifically targeting ecDNA-driven tumors, thereby enabling selective treatments for patients whose tumor genetic profiles make them most likely to benefit from our novel therapeutic candidates.

See the article here:
Boundless Bio Announces Publication in Nature Genetics Detailing the Association Between Extrachromosomal DNA-Based Oncogene Amplification and Poor...

Read More...

Unless true origin of coronavirus is identified, another Chinese pandemic is in the offing – WION

August 18th, 2020 9:00 am

To date, no one has stated the urgent universal need to aggressively investigate the true origin of SARS-CoV-2, the coronavirus responsible for COVID-19, better than Karl and Dan Sirotkin in their August 12, 2020 article Might SARSCoV2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?

Despite claims from prominent scientists that SARSCoV2 indubitably emerged naturally, the etiology of this novel coronavirus remains a pressing and open question: Without knowing the true nature of a disease, it is impossible for clinicians to appropriately shape their care, for policymakers to correctly gauge the nature and extent of the threat, and for the public to appropriately modify their behaviour.

As the authors correctly note, serial passage, that is, the repeated re-infection within an animal or human population allows a virus to specifically adapt to the infected species.

That process occurs naturally in the wild, but it can be greatly accelerated in the laboratory by deliberate serial passaging of viruses in cell culture systems or animals, potentially leaving few or no traces as to whether the adapted viruses are naturally-occurring or laboratory-manipulated.

That type of "gain of function" experimentation can become particularly dangerous if viruses are adapted for human infection by serial passaging them through cell cultures and animal models that have been genetically-modified to express human receptors.

There are numerous scientific publications describing serial passaging of coronaviruses through humanised cell cultures and animal models, thus potentially creating a new coronavirus pre-adapted for human infection.

At present, the scientific consensus is that SARS-CoV-2 came from bats, but how it evolved to infect humans remains unknown.

China has claimed that a bat coronavirus named RaTG13 is the closest relative to SARS-CoV-2, but RaTG13 is not actually a virus because no biological samples exist. It is only a genomic sequence of a virus for which there are now serious questions about its accuracy.

In contrast, Dr Li-Meng Yan, a Chinese virologist and whistleblower, has implied that RaTG13 may have been used to divert the worlds attention away from the true source of the COVID-19 pandemic, a novel coronavirus that originated in military laboratories overseen by China's Peoples Liberation Army and created by the manipulation of Zhoushan coronaviruses ZC45 and/or ZXC21.

SARS-CoV-2 has signs of serial passaging and the direct genetic insertion of novel amino acids sequences for which no natural evolutionary pathway has been identified.

Although SARS-CoV-2 appears to have the backbone of bat coronaviruses, its spike protein, which is responsible for binding to the human cell and its membrane fusion-driven entry, has sections that do not appear in any closely-related bat coronaviruses.

SARS-CoV-2s receptor binding domain, the specific element that binds to the human cell, has a ten times greater binding affinity than the first SARS virus that caused the 2002-2003 pandemic.

Furthermore, SARS-CoV-2 appears to be pre-adapted for human infection and has not undergone a similar natural mutation process within the human population that was observed during the 2002-2003 SARS outbreak.

Those observations plus the inexplicable genetic distance between SARS-CoV-2 and any of its potential bat predecessors suggest an accelerated evolutionary process obtained by laboratory-based serial passaging through genetically-engineered mouse models containing humanised receptors previously developed by China.

The other unique feature of SARS-CoV-2 is a furin polybasic cleavage site that facilitates membrane fusion between the virus and the human cell and widely known for its ability to enhance pathogenicity and transmissibility, but also is not present in any closely related bat coronaviruses.

There are no readily-available animal models to produce a unique furin polybasic cleavage site by serial passaging, but techniques for the artificial insertion of such furin polybasic cleavage sites by genetic engineering have been used for over ten years.

To paraphrase Karl and Dan Sirotkin, unless the zoonotic hosts necessary for completing a natural jump from animals to humans are identified, the dualuse gainoffunction research practice of viral serial passage and the artificial insertion of unique viral features should be considered viable routes by which SARS-CoV-2 arose and the COVID-19 pandemic was initiated.

Lawrence Sellin, PhD is a retired US Army Reserve colonel. He has previously worked at the US Army Medical Research Institute of Infectious Diseases and conducted basic and clinical research in the pharmaceutical industry. His email address is lawrence.sellin@gmail.com.

(Disclaimer: The opinions expressed above are the personal views of the author and do not reflect the views of ZMCL.)

Go here to read the rest:
Unless true origin of coronavirus is identified, another Chinese pandemic is in the offing - WION

Read More...

SinoPharm’s Inactivated Coronavirus Vaccine | In the Pipeline – Science Magazine

August 18th, 2020 9:00 am

So now we have some clinical data on yet another category of vaccine: SinoPharms inactivated coronavirus candidate. This is one of the classic vaccine techniques, where an infectious virus is altered by some sort of protein-denaturing treatment (heating or reactive chemistry) to make it noninfectious. But such particles can retain enough of their protein surfaces to set off a useful immune response the tricky part is inactivating the virus enough so that it cant infect cells and replicate, but not so much that it presents totally different proteins to the immune system and raises a response that wont help against the real virus.

In SinoPharms case, they inactivated the coronavirus with beta-propiolactone, which is a classic protein-alkylating compound. BPL is a strained four-membered ring that is ready to be attacked and opened by pretty much any sort of nucleophile, including protein side chains from amino acids such as Cys or Lys. The compound is used for chemical disinfection (surgical instruments and the like), but thats not a casual application, because its carcinogenic by itself. It works out for such applications, though, because its very volatile (and thus easy to remove by vacuum or heating), much like another small reactive and toxi) strained ring compound, ethylene oxide. So theres no danger in using BPL to inactivate a virus the question, as mentioned, is going to be whether youve inactivated it too much.

Patients in the Phase I trial got 2.5, 5, or 10 micrograms of this agent at Day 0, Day 28, and a third time at Day 56. There were 24 patients in each group, plus an equal-sized placebo group that just got alum adjuvant injections. In the Phase II trial, the 5 microgram dose was chosen, and there were two groups: injection at Day 0 and Day 14, or injection at Day 0 and Day 21, with 84 patients in each group and a 28-patient placebo group for each. Median ages were around the early 40s, slightly more men than women. Adverse reactions appear to have been nothing remarkable pain at the injection site mostly, with very little systemic stuff like fever or fatigue, which certainly appears to be the mildest profile of the vaccines that weve seen so far.

As for neutralizing antibodies, it looks like the three-dose Phase I trial had an odd dose-response. The medium dose was actually slightly worse than either the low or high one. Meanwhile, in the Phase II, which was done with that medium five-microgram dose, the antibody response (measured two weeks after the second dose) was not as strong as with the full three-dose schedule, but the 0/21 day dosing schedule led to a better response than the 0/14 one. It appears from the Phase II data that one of the 42 patients who were tested for antibody response in that group did not seroconvert at all. The geometric mean titer values for the neutralizing antibodies (247 for the 0/21 group) appear to be in the range of other Phase I data reported, although its not easy to make a head-to-head comparison with any certainty. There is no comparison in the study with a convalescent plasma group, but as weve been seeing, those samples tend to be pretty variable themselves. There are also no data on T-cell responses.

So this is a rather preliminary report (as the authors themselves note), but its the first one we have on an inactivated vaccine. Like all of the others so far except the J&J Ad26 one, this candidate will also need a booster shot. The small and mild adverse-event reactions here are really the main thing that stands out if youre a glass half full person, then you can be glad about that, but if youre a glass-half-empty one, you might wonder about the overall robustness of the immune response. Were going to need more data to make any calls about that, and (just as with every other vaccine under development!) the real numbers were waiting on for efficacy. How many people will this (or any) vaccine protect, and how well? Stay tuned.

Read more:
SinoPharm's Inactivated Coronavirus Vaccine | In the Pipeline - Science Magazine

Read More...

Page 417«..1020..416417418419..430440..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick